Safety Alerts & Recalls

What does this mean?

Because long-term use of hormone replacement therapy is linked to an increased risk of breast cancer and other serious conditions, most doctors prescribe this medication for short periods of time. If you have used hormone replacement therapy for more than 2 years, you may want to talk to your doctor about the benefits of the medicine versus the risk of breast cancer and other risks associated with (or related to) continuing to take this medicine. Your increased risk of breast cancer will decrease once you stop taking hormone replacement therapy.

Update on the Risk of Breast Cancer with Hormone Replacement Therapy

Two recently published articles better describe the link between hormone replacement therapy (HRT) and risk of breast cancer. First, the increased risk of breast cancer occurs within 2 to 3 years of beginning hormone replacement therapy. Second, the risk of getting breast cancer decreases after you stop taking hormone replacement therapy.

Hormone replacement therapy medicines include conjugated estrogens (Premarin), estradiol (Estrace, Climara, Vivelle and others), medroxyprogesterone (Provera, Cycrin), combination conjugated estrogens with medroxyprogesterone (Prempro, Premphase), and other progestins (progesterone, hydroxyprogesterone).

For more information please visit: more information here and

more information here

Source: MediGuard CRT
Publication Date: 2009-06-08
Last Updated: 2009-12-05

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.